The major objective of this course is to provide a detailed insight into the practical aspects and approaches of process scale-up for different unit operations and technologies.
When QUALITY meets OPEX in manufacturing
PHARMA and Biotech leaders understand the importance of shifting from a culture of compliance to a culture of quality.
Times of transformation call for increasing overall quality and efficiency while lowering costs in order to follow regulations and maintain a competitive edge.
Can you sustain the leadership commitment and employee engagement required in the continuous improvement of quality? Do you know how to overcome resistance to change and successfully lead engaged employees who see the importance of the overall strategy?
On 22 – 23 September 2016, Vienna will be the place where Quality meets OPEX. Organized by Fleming., delegates will have the unique opportunity to attend two events in one and meet 100+ industry professionals under one roof.
At the 12th Annual Quality in Pharma & Biotech Forum, participants will discuss with leading experts how to translate a quality culture into operations and close the loop on their desired level of quality. They will gain insight into GMP inspection trends, data integrity requirements, quality metrics, Lean Six Sigma approach in a quality unit, CMO quality oversight, quality risk management in issue handling, serialization and technology transfer strategies.
The 12th Annual OPEX in Pharma & Biotech Forum will provide insights into developing defect-free processes. Attendees will find out how to achieve manufacturing excellence through more competitive improvement strategies in Digitalization, Six Sigma and advanced technologies such as 3D printing. Experts will explain how to lead initiatives even further, develop operating models in an autonomous work environment and create strong learning loops to adjust the operational excellence approach.
One day prior to the event, on 21 September, a pre-conference site visit to the facilities of Baxalta, one of the largest biopharma companies in Austria, will be prepared for interested participants.
Interested in this topic?
Targeted Drug Delivery
Gain detailed overview of the newest strategies in drug delivery and targeting.
Next Generation Antibody Therapeutics
This focused 2-day training will cover the discovery, engineering and production of next-generation antibodies, antibody fragments, bispecific Abs, innovative ADCs and more. Follow the path from their discovery and selection through engineering and expression to production and regulatory issues.
White Paper: Beyond the Cold Chain
Take a Good Look at the Future of Corporate Universities
There are four things corporate universities can do to avoid becoming irrelevant in the digital age.
Ready for the new GCP ICH E6 (R2) addendum?
On the 23rd of July 2015, the EMA's Committee for Human Medicinal Products released the Guideline for Good Clinical Practice E6(R2) for consultation. On the 14th of June 2017, it will come into effect and influence everyone involved in the clinical research process. What does it mean to pharma and biotech companies, sponsors, CROs, research institutes and third-party organizations?